C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology

Contributed by: Business Wire

Logo

Tags

Research

Philanthropy

Biotechnology

Fund Raising

Pharmaceutical

Health

Foundation

Other Philanthropy

Science

Oncology

C-Further

More Like This

C-Further announces major partnership with GOSH Charity to drive innovation in childhood cancer treatment

XNK Therapeutics receives funding from Sweden's innovation agency Vinnova

Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference

PR Newswire associated0

Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting